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● We report a carcinoma that is, to the best of our knowl-
edge, the first case of a mixed mucus-secreting and on-
cocytic carcinoma of the thyroid. We also describe the his-
tochemical, immunohistochemical, and ultrastructural fea-
tures of this tumor. A 59-year-old man complaining of se-
vere bone pain and weight loss underwent clinical and
radiologic investigations. The studies revealed a nodule in
the left thyroid lobe that was ‘‘cold’’ by 131I scintiscan and
multiple lytic lesions of the skeleton that showed increased
uptake by 99mTc-Sestamibi scintiscan. Left hemithyroidec-
tomy was performed and the surgical specimen contained
a well-circumscribed nodule of 3 cm in the greatest di-
ameter. Light microscopy showed an oncocytic carcinoma
with an area of glandular and papillary proliferation of mu-
cin-producing cells. A double histochemical approach (Al-
cian blue–periodic acid–Schiff and Alcian blue–high-iron
diamine) combined with ultrastructural investigation con-
firmed the presence of true mucus, ruling out the presence
of breakdown products of thyroglobulin. Ultrastructural
and immunohistochemical studies, together with clinical
findings, excluded a possible metastatic origin of the mu-
cin-producing component.
(Arch Pathol Lab Med. 2000;124:1547–1552)
The occasional production of mucinlike substances bycells of primary thyroid neoplasms is a well-known
phenomenon1; nevertheless, true primitive mucinous (ad-
eno)carcinomas of the thyroid gland are extremely rare
and their place in the classification of thyroid tumors is
still uncertain.2 Mucinous3–5 and mucoepidermoid6–9 car-
cinomas of the thyroid have been described and, in ad-
dition, mucins have been found in lymph node metastases
from papillary carcinomas,10 as well as in follicular,11 med-
ullary,12,13 and undifferentiated14,15 cancers. To the best of
our knowledge, cases of oncocytic carcinoma of the thy-
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roid showing mucin production have never been de-
scribed.
Oncocytic carcinoma of the thyroid gland, also known
as Hu¨rthle-cell carcinoma, is a malignant tumor exclu-
sively or predominantly composed of oncocytes (over 75%
of cells), which are cells showing granular cytoplasmic eo-
sinophilia and a ‘‘swollen’’ appearance resulting from mi-
tochondrial accumulation. These tumors account for 2% to
3% of all thyroid cancers2 and seem to behave in a more
aggressive fashion than other well-differentiated thyroid
carcinomas.17,18
In this study we describe the clinical and pathologic
features of an oncocytic carcinoma of the thyroid showing
an area of mucinous differentiation. We designated this
tumor a ‘‘mixed mucus-secreting and oncocytic carcino-
ma.’’
REPORT OF A CASE
A 59-year-old man presented in February 1998 with severe
bone pain, localized primarily to the cervical and thoracic spine
and chest wall. The patient reported a weight loss of 13 kg in the
last few months. Radiographic examination of the skeleton
showed collapse of the third dorsal vertebra and multiple oste-
olytic lesions in other vertebrae, ribs, sternum, pelvic bones, and
femurs. Magnetic resonance imaging and 99mTechnetium-diphos-
phonate scintiscan of the whole skeleton were suggestive of sec-
ondary metastasis of an occult malignancy. On physical exami-
nation, a thyroid nodule was found in the left lobe. Ultrasonog-
raphy identified a hypodense lesion of 3 cm in the greatest di-
ameter that did not trap the tracer during an 131I scintiscan. Fine
needle aspiration was performed and the cytologic specimens
were highly cellular and composed of oncocytic cells. Ultrasound
study of the abdomen and pelvis was also performed and the
only significant finding was a hypodense subcapsular bilobar
area of the prostate; the biopsy of this lesion was diagnostic for
atypical acinar hyperplasia with a microfocus of a moderately
differentiated prostatic adenocarcinoma. The patient’s thyroid
function was normal (thyroxin, 2.3 pmol/L; thyroid-stimulating
hormone, 1.3 IU/L), whereas serum thyroglobulin (726 mg/L;
normal, 10–20 mg/L) and carcinoembryonic antigen (CEA, .70
mg/L; normal, ,5 mg/L ) levels were elevated. Serum prostate-
specific antigen (PSA) was slightly elevated (10.3 ng/mL; normal,
,4 ng/mL), but the PSA ratio was normal (0.09).
The patient underwent left hemithyroidectomy. After surgery,
additional computerized tomographic scans were negative for
metastatic lesions in the lungs, liver, and other internal organs.
Scintigraphy with 99mTc-Sestamibi revealed uptake of the tracer
in the mediastinum and left hemithorax, corresponding to oste-
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Antibodies and antisera employed
Antibody or Antiserum P or M (clone)* Dilution Source
Mitochondrion
Thyroglobulin
Carcino-embryonic antigen
Calcitonin
Chromogranin A
Prostatic specific antigen
Pepsinogen II
E-cathepsin
Salivary amylase
Ki-67
p53
M (113-1)
P
M (B01-94-11M)
M (SILVIA)
M (Phe 5)
P
P
P
P
M (MIB-1)
M (DO7)
1/100
Undiluted
Undiluted
1/200
1/50
Undiluted
1/2000
1/2000
1/100
1/50
1/1000
BioGenex, San Ramon, Calif
Ortho, Raritan, NJ
BioGenex
Ortho
Enzo, New York, NY
Dako, Copenhagen, DK
Gift of Samloff†
Gift of Samloff†
Biogensis, Bournemouth, UK
Ylem, Roma, I
Dako
* P indicates polyclonal; M, monoclonal.
† Kind gift of Dr I. M. Samloff, Veterans Administration Medical Center, Sepulveda, Calif.
olytic lesions of the ribs and sternum. One month after hemithy-
roidectomy, external radiotherapy was started because of bone
metastases. No regression occurred and the patient died in July
1998. Postmortem examination was not carried out.
MATERIALS AND METHODS
Samples of the tumor were fixed in buffered formalin (form-
aldehyde 4% wt/vol acetate buffer 0.005 mol/L) and routinely
processed in paraffin wax. Sections were stained with hematox-
ylin-eosin (H&E), Alcian blue (pH 2.5)–periodic acid–Schiff (AB-
PAS), and Alcian blue (pH 2.5)–high-iron diamine (AB-HID).
Immunohistochemistry was performed using the antibodies
and antisera listed in the Table. Antithyroglobulin serum was
employed as a thyroid marker and the antimitochondrial anti-
body was used to assess the oncocytic nature of neoplastic cells.
Anticalcitonin and anti–chromogranin A antibodies were em-
ployed to exclude a medullary thyroid carcinoma. Antibodies di-
rected against prostatic-specific antigen, pepsinogen II, cathepsin
E, and salivary amylase were used to exclude the possibility that
the mucinous area represented a metastasis from a primary tu-
mor in the prostate, digestive tract, or salivary glands, respec-
tively. In addition, the anti–carcinoembryonic antigen antibody
was used to evaluate the mucin-producing component. Anti–Ki-
67 and anti-p53 monoclonal antibodies were employed to inves-
tigate the proliferative index and p53 nuclear accumulation in the
2 different components. For immunohistochemical stains, 3-mm
sections mounted on poly-L-lysine–coated slides were used. After
hydration through graded alcohols to water, endogenous perox-
idase activity was inhibited with 3% hydrogen peroxide for 10
minutes. Primary antibody (Table) incubations were performed
at 48C for 18 hours followed by the avidin-biotin complex tech-
nique.19 Immunoreactions were developed using 0.03% 3,39-dia-
minobenzidine tetrahydrochloride. Sections immunostained with
antibodies directed against salivary amylase and p53 were pre-
treated with 0.001 mol/L citrate buffer (pH 6) for 10 minutes in
a microwave oven at 600 W. Sections stained with anticalcitonin
antibody were pretreated with 0.05% trypsin in 0.05 mol/L tris-
buffered saline (pH 7.4). Sections stained for Ki-67 (MIB-1) were
pretreated with 0.05% trypsin in 0.05 mol/L tris-buffered saline
(pH 7.4) before microwave treatment.
The Ki-67 (MIB-1) proliferative index was determined by
counting the number of MIB-1-positive cells in a minimum of
500 neoplastic cells in both oncocytic and mucinous areas. The
percentage of p53-immunoreactive cells was semiquantitatively
evaluated.
For ultrastructural examination, formalin-fixed samples of the
neoplasm were used. The specimens were postfixed in 1% os-
mium tetroxide (Merck, Darmstadt, Deutschland) in 0.1 mol/L
cacodylate buffer pH 7.3 (Merck), dehydrated in ethanol, and em-
bedded in Epon-Araldite (Epon 812, Durcupan ACM: Fluka,
Buchs, Switzerland; DDSA: Polysciences, Warrington, Pa, USA;
DMP-30: Serva, Heidelberg, Deutschland). Ultrathin sections
were cut with a diamond knife, stained with uranyl acetate (Poly-
sciences) and lead citrate (Merck), and examined using a Zeiss
EM10 transmission electron microscope.
RESULTS
Pathologic Findings
At gross examination, a well-circumscribed encapsulat-
ed nodule measuring 3 cm in the greatest dimension was
found in the left hemithyroidectomy specimen. The tumor
showed a solid tan aspect with multiple foci of hemor-
rhage. A peripheral poorly defined whitish area of ap-
proximately 1 cm in diameter was also seen within the
nodule.
Microscopically, the lesion was encapsulated and re-
vealed to be composed primarily of polygonal cells with
abundant granular eosinophilic cytoplasm, showing the
classic features of oncocytic (Hu¨rthle) cells, arranged in a
microfollicular and solid/trabecular pattern (Figure 1).
The nuclei were round with finely dispersed chromatin
and evident nucleoli, eccentrically located. Mitotic figures
were extremely rare (1 figure per 30 high-power fields).
Focal capsular infiltration and vascular neoplastic emboli
were observed in the surrounding nonneoplastic thyroid,
suggesting malignancy. In samples taken from the whitish
area, papillary and glandular structures formed by colum-
nar cells with basophilic cytoplasm and basally located
nuclei were seen (Figure 1). A strongly alcianophilic ma-
terial was seen within the glandular lumens and spaces
among papillae. Alcian blue staining was also observed in
intracytoplasmic vacuoles and at the apical cell borders
(Figure 2), whereas no HID stain was observed. The nuclei
showed some pleomorphism and were larger and more
irregular in shape than those seen in the oncocytic zone.
The chromatin was clumped, giving the nuclei a clear ve-
siculated appearance, and some elements had multiple eo-
sinophilic nucleoli. The mitotic index in this area was 6
mitoses per 10 3400 high-power fields. This ‘‘mucinous’’
area seemed to have expanding edges, compressing the
surrounding neoplastic parenchyma; however, in several
areas, continuity with the typical oncocytic proliferation
was evident.
Immunohistochemistry
All neoplastic cells, both those in the oncocytic zone and
those in the papillary and glandular area, were immu-
noreactive for antimitochondrial antibody; in the former
cells, immunostaining was very strong with a crowded
granular cytoplasmic pattern, whereas in the latter cells,
it was granular and dotlike (Figure 3). Weak and zonal
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Figure 1. Mixed mucus-secreting and oncocytic carcinoma of the thy-
roid showing an oncocytic solid component (bottom) and mucin-pro-
ducing glandular structures (top) (hematoxylin-eosin, original magnifi-
cation 3200).
Figure 2. Mucus-secreting area showing Alcian blue staining in glan-
dular lumina and in the cytoplasm of cells (inset) (Alcian-blue/PAS,
original magnification 3200).
immunoreactivity for thyroglobulin was only seen in the
typical oncocytic cells, whereas an intense expression of
CEA was exclusively seen in the mucinous elements. No
staining was noted using antibodies directed against cal-
citonin and chromogranin A, excluding the possibility of
a medullary carcinoma of the thyroid. Antibodies or an-
tisera directed against PSA, pepsinogen II, E-cathepsin,
and salivary amylase gave negative immunoreactions, rul-
ing out metastasis from the prostate, digestive tract, and
salivary glands.
The Ki-67 (MIB-1) proliferative index was lower in the
oncocytic component (2%) than in the mucinous area
(54%) of the tumor (Figure 4). Nuclear p53 accumulation
was found in a few scattered oncocytes (less than 1%),
whereas it was detected in about 40% of mucin-producing
cells (Figure 5).
Electron Microscopy
Ultrastructural examination was performed on speci-
mens obtained from both the oncocytic and the mucinous
areas of the tumor. Oncocytic cells had nuclei with some
indentations; the chromatin was moderately dispersed and
the nucleoli were generally small and eccentric. The cy-
toplasm was typically packed with numerous mitochon-
dria with few residual organelles (Figure 6). In the mucin-
ous area, neoplastic cells showed basally located, deeply
indented nuclei, with clumped chromatin primarily locat-
ed along the nuclear membrane. Nucleoli were prominent
and often multiple. These cells had apical borders pre-
senting short and irregular microvilli. Numerous mucin-
ous granules were observed below the secretory pole and
these granules sometimes exhibited electron-dense cores
(Figure 7). Moreover, a large number of mitochondria
were also present in the cytoplasm of these cells, although
they were less numerous than in the oncocytic area. No
colloid material or colloid droplets were seen.
COMMENT
Although primary mucinous (adeno)carcinomas of the
thyroid have been described,3–5 their recognition as a true
entity is still a matter of debate. In contrast, mucin pro-
duction by cells of several thyroid neoplasms is a well-
known phenomenon, as previously reported.1,2,10–15
A mucin-producing neoplasm within the thyroid poses
at least 2 problems: the first problem concerns the primary
or metastatic nature of the tumor; the second problem con-
cerns the difficulty of assessing whether the mucinlike ma-
terial observed in the context of the neoplasm is true mu-
cus. Metastatic involvement of the thyroid from distant
malignancies, such as carcinomas of the lung, gastrointes-
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Figure 3. Mitochondrion immunoreactivity in neoplastic cells of the
mucus-secreting component and in neoplastic emboli within the tumor
capsule (inset) (avidin-biotin complex technique with hematoxylin
counterstain, original magnification 3200).
Figure 4. Immunoreactivity for Ki-67 (MIB-1) in mucin-secreting cells
(avidin-biotin complex technique with hematoxylin counterstain, orig-
inal magnification 3400).
tinal tract, kidney, and skin, has been reported.2,20 Authors
describing primary mucinous tumors of the thyroid have
ruled out a metastatic nature by considering clinical data,3
by evaluating follow-up data,5 or by detecting mucins to-
gether with colloid11 or thyroglobulin4 in these neoplasms.
The diagnosis of ‘‘mucin-secreting tumor’’ of the thyroid
has traditionally relied upon apparent positivity of vari-
ous histochemical methods for detection of mucinlike sub-
stances, commonly employed for the study of either gas-
trointestinal or bronchial mucin-secreting epithelia, such
as periodic acid–Schiff, Alcian blue, mucicarmine, and oth-
er methods. These techniques should be employed and
interpreted with caution in the study of thyroid tumors,
as they may detect breakdown products of thyroglobulin
and colloid and not true mucinlike substances.21
We considered the possibility that our tumor could be
a thyroid metastasis from a cancer located in another site,
namely in the prostate, where a biopsy disclosed a micro-
focus of adenocarcinoma. We first ruled out this possibil-
ity based on the low serum levels of PSA, followed by the
lack of PSA immunoreactivity in the thyroid neoplastic
tissue. In addition, the extensive imaging examination the
patient underwent failed to reveal any possible site for a
primary malignancy other than the thyroid. Furthermore,
the positive result of the 99mTc-Sestamibi scintiscan, which
has been reported to identify Hu¨rthle cell tumors and
their metastases,22 as well as the raised thyroglobulin lev-
els, supported the likelihood that bone metastases could
be attributed to the thyroid oncocytic carcinoma. On the
other hand, immunohistochemistry showed no positivity
for PSA, pepsinogen II, E-cathepsin, and salivary amylase,
thus ruling out primaries from prostate, digestive tract,
and salivary glands. In addition, the absence of immu-
noreactivity for chromogranin A and calcitonin excluded
the possibility of a medullary thyroid carcinoma, which
has been reported to have mucinous differentiation.13 In
contrast, both the classic oxyphilic and the mucin-produc-
ing components stained strongly for antimitochondrial an-
tibody, which recognize oncocytes.23 This pattern demon-
strated that both areas were rich in mitochondria and sug-
gested that the 2 areas should be considered as 2 different
aspects of the oncocytic carcinoma. Ultrastructural exam-
ination supported this hypothesis, showing that neoplastic
cells of the mucinous area were very rich in mitochondria
and suggesting that this component could be considered
as a mucinous differentiation of the Hu¨rthle cell carcino-
ma.
The lack of immunoreactivity for thyroglobulin in the
mucinous component, at first sight, argues against a thy-
roid primary. However, several primary thyroid tumors
have been reported to be thyroglobulin-negative or weak-
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Figure 5. Immunostaining for p53 in the mucinous component of the
tumor (avidin-biotin complex technique with hematoxylin counter-
stain, original magnification 3400).
Figure 6. Cells of the oncocytic component showing cytoplasm
packed with mitochondria (uranyl acetate-lead citrate, original mag-
nification 328 000).
Figure 7. Apical pole of a mucin-secreting
cell. Note microvilli protruding in the gland
lumen, mucinous secretory granules (upper
right), and mitochondria (bottom left) (uranyl
acetate-lead citrate, original magnification
344 800).
ly positive.3,5,6,8,24 It is possible that thyroglobulin produc-
tion decreases as the follicular cells gain mucinous differ-
entiation. Furthermore, it has been suggested that onco-
cytic tumors of the thyroid produce only small amounts
of thyroglobulin.25–27 So, if the mucinous aspects of our
neoplasm are to be considered as a mucin-producing dif-
ferentiation of a Hu¨rthle-cell carcinoma, the lack of thy-
roglobulin immunoreactivity is not surprising. Immuno-
reaction for CEA was observed in the mucin-producing
area of the present case. Among primary tumors of the
thyroid, CEA-positivity is a feature of medullary carci-
nomas,2 but as noted previously, this diagnosis was ex-
cluded by immunohistochemical findings. However, spo-
radic cases of Hu¨rthle-cell carcinoma and anaplastic car-
cinoma of the thyroid have been found to produce CEA.26–29
Moreover, a case of mucin-producing poorly differentiated
adenocarcinoma of the thyroid has been reported to be
CEA-positive.15 Finally, intraductal oncocytic papillary
mucinous tumors have been described in the pancreas and
some of them were CEA-positive.30,31
The study of the mucinous component of the neoplasm
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was performed using 2 stains: (1) the AB-PAS stain, which
distinguishes between acid mucins stained blue by AB
and neutral mucins stained magenta by PAS; and (2) the
AB-HID stain, which differentiates sulfomucins stained
brownish by HID and sialomucins stained blue by AB.
This double approach allowed us to evaluate the whole
spectrum of the possible mucin secretion. Considering that
breakdown products of thyroglobulin are neutral glyco-
proteins that are stained by PAS, PAS staining in thyroid
tumors should not suggest true mucus production.21 In
our case, we found strong alcianophilia in both extra- and
intracellular spaces, with no positivity for other stains
with the exception of some extracellular PAS-positivity.
Such results favor genuine mucin production. The absence
of PAS staining indicates that the mucin did not arise from
the breakdown of thyroglobulin. Thus, we believe that it
is correct to define this component of the tumor as ‘‘mu-
cus-secreting.’’ In addition, HID staining, which is a typ-
ical feature of colorectal and biliopancreatic adenocarci-
nomas, was not found in our tumor. This helps us to ex-
clude a metastatic nature of the mucinous component. Ul-
trastructural study showed numerous mucinous granules
with an electron-dense core. This finding gave further con-
fidence to the hypothesis that the mucinlike material ob-
served at light microscopy was true mucus produced by
neoplastic cells of the glandular and papillary component
of the tumor.
The histogenesis of mucin-producing neoplasms of the
thyroid gland has been a debated and is a controversial
issue. Diaz-Perez et al5 have suggested that the mucinous
thyroid tumor they described could have originated from
thyroglossal vestiges, because thyroglossal cysts or sinus
are lined by ciliated pseudostratified respiratory type
cells, squamous cells, and mucus-secreting columnar cells.
Rhatigan et al8 speculated that salivary gland remnants
trapped in the developing thyroid were responsible for
their case of mucoepidermoid cancer. The concurrent pro-
duction of mucinlike substances and thyroglobulin in
some tumors11,32,33 has suggested the so-called ‘‘dual dif-
ferentiation’’ hypothesis,33 which assumes differentiation
of a primitive endodermal cell along both an endocrine
and a mucus-secreting line. This phenomenon is observed
in other endodermal-derived organs, such as the stomach
and intestine.34 However, none of these hypothesis has
been definitely proved.
The neoplasm that we have described was very aggres-
sive from a clinical and biological point of view, resulting
in diffuse bone metastases and death within 5 months of
diagnosis. This dramatic course may be related to the
presence of the mucinous component, as suggested by the
literature concerning ‘‘pure’’ mucinous carcinomas and
mucoepidermoid carcinomas of the thyroid.3,4,6,8 These
data lead to the conclusion that these tumors are probably
more aggressive than other more common thyroid carci-
nomas lacking mucin production. According to this hy-
pothesis, the mucinous component of our tumor had the
features of a highly malignant neoplasm, showing marked
cytologic atypia, high mitotic and Ki-67 indices, and p53
nuclear accumulation.
In conclusion, this report represents the first description
of a mucin-producing oncocytic carcinoma of the thyroid
that was biologically aggressive and led to a poor clinical
outcome.
This study was supported by a grant of the University of In-
subria, Varese, Italy.
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